Prostate cancer Trials in Belfast, United Kingdom
Conditions / Prostate cancer / Belfast, United Kingdom
Prostate cancer is a medical condition with active clinical research programs worldwide.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01584258 | Prostate Advances in Comparative Evidence | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02003924 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT04905069 | Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer | ACTIVE_NOT_RECRUITING | — |
| NCT00959023 | Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer | UNKNOWN | — |
| NCT01193244 | Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT01522443 | Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer | TERMINATED | PHASE3 |
| NCT00268476 | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT02759783 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases | UNKNOWN | PHASE2/PHASE3 |
| NCT04136353 | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02960022 | A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study | RECRUITING | PHASE2 |